Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01264510

Evaluation of the Effectiveness of Bone-anchored Hearing Aids (Baha)

The Evaluation of the Effectiveness of Bone-anchored Hearing Aids (Baha) in Patients With Conductive or Mixed Hearing Loss, or Unilateral Deafness

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A bone-anchored hearing aid (Baha) consists of a titanium implant located at the mastoid, and a sound processor connected with the implant. The sound processor delivers bone conducted stimuli to the cochlea, bypassing the outer and middle ear. Some patients who are unable to wear or do not benefit from a conventional air-conduction hearing aid, are candidate for a Baha. Typically, these patients suffer from a conductive or a mixed hearing loss. Recently however, Baha's are also being recommended in patients with unilateral deafness. Sound coming from the deaf side is captured and transmitted through bone conduction to the normal inner ear. The overall benefit of a Baha is more difficult to assess in those patients. Therefore, the goal of the current study is to examine the benefit of a Baha in patients with different audiological profiles (unilateral or bilateral conductive or mixed hearing loss, and unilateral deafness). Special attention will be given to predictive determinants of the benefit with a Baha, and to the improvement of pre-operative criteria and counseling of patients.

Conditions

Interventions

TypeNameDescription
OTHERaudiological test batteryroutine audiological measurements.

Timeline

Start date
2010-03-01
Primary completion
2015-08-01
Completion
2015-08-01
First posted
2010-12-21
Last updated
2022-12-29

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01264510. Inclusion in this directory is not an endorsement.